CubaHeadlines

Herpes Simplex Virus

Discover advances in Herpes Simplex Virus (HSV) treatment, including FDA-approved Hovilpri for resistant lesions in immunocompromised adults, and emerging research.

FDA Approves Hovilpri for Herpes Lesions Resistant to Antiviral Treatment in Immunocompromised Adults
FDA Approves Hovilpri for Herpes Lesions Resistant to Antiviral Treatment in Immunocompromised Adults

Published on 10/10/2026